Physician Briefing
- Allergy
- Anesthesiology
- Cardiology
- Cosmetic Surgery
- Critical Care
- Dermatology
- Diabetes & Endocrinology
- Emergency Medicine
- Family Practice
- Gastroenterology
- Geriatrics
- Hematology & Oncology
- HIV & AIDS
- Infectious Disease
- Internal Medicine
- Nephrology
- Neurology
- Nursing
- OBGYN & Women's Health
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pain Management
- Pathology
- Pediatrics
- Pharmacy
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Surgery
- Urology
Oncology News
-
Fasting Augments Chemo in Cancer Cells, Mouse Models
Short cycles of starvation (fasting) sensitizes mammalian cancer cells to chemotherapeutic agents, and may increase the effectiveness of chemotherapy against cancer cells and in mouse models, according to an experimental study published online Feb. 8 in Science Translational Medicine.
-
Acute Myeloid Leukemia Risk Factors ID'd in Texas Adults
Solvent exposure, smoking, and obesity are significant risk factors for de novo acute myeloid leukemia in Texas, according to a study published online Feb. 1 in Cancer.
-
Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued
New evidence-based clinical practice guidelines have been issued for the prophylaxis of venous thromboembolism in nonsurgical patients; the guidelines have been published in a supplement to the February issue of CHEST.
-
Intracerebroventricular Opioid Infusion Feasible at Home
Intracerebroventricular infusion of opioids is safe and effective for the treatment of nonresponsive pain in terminally-ill patients in home settings, according to a review published online Feb. 1 in the British Journal of Clinical Pharmacology.
-
Radiation Risks From Diagnostic Procedures Examined
National strategies should be developed for the use of evidence-based criteria and improved oversight of equipment to minimize radiation exposure for patients undergoing diagnostic procedures, according to a study published online Feb. 3 in CA: A Cancer Journal for Clinicians.
-
Soy Isoflavones Don't Reduce Breast Epithelial Proliferation
Mixed soy isoflavone supplements given over a six-month period show no significant effect in reducing the proliferation of breast cancer epithelial cells in healthy women, according to a study published in the February issue of Cancer Prevention Research.
Oncology Conference Highlights
- ASCO Genitourinary Cancers Symposium, Feb. 2-4, 2012
- ASCO Gastrointestinal Cancers Symposium, Jan. 19-21, 2012
- American Society of Hematology, Dec. 10-13, 2011
- San Antonio Breast Cancer Symposium, Dec. 6-10, 2011
- American College of Gastroenterology, Oct. 28-Nov. 1, 2011
More Oncology Conference Highlights